share_log

諾輝健康：截至二零二三年十二月三十一日止月份之股份發行人的證券變動月報表

NH HEALTH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

香港交易所 ·  Jan 4 04:44
Summary by Moomoo AI
諾輝健康於2024年1月4日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本結存維持在1,000,000,000美元，每股面值0.00005美元，總額50,000美元。已發行股份方面，本月底結存為457,813,108股，較上月增加1,996股。該增加源於2023年12月行使的首次公開發售前股權激勵計劃下的1,996份購股權。此外，公司於2023年6月至10月期間購回的股份尚未註銷，總數為9,058,500股。報告中未提及有關香港預託證券的資料。執行董事陳一友確認，所有證券發行均獲董事會授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
諾輝健康於2024年1月4日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本結存維持在1,000,000,000美元，每股面值0.00005美元，總額50,000美元。已發行股份方面，本月底結存為457,813,108股，較上月增加1,996股。該增加源於2023年12月行使的首次公開發售前股權激勵計劃下的1,996份購股權。此外，公司於2023年6月至10月期間購回的股份尚未註銷，總數為9,058,500股。報告中未提及有關香港預託證券的資料。執行董事陳一友確認，所有證券發行均獲董事會授權，並符合香港聯合交易所有限公司證券上市規則的相關要求。
Novi Health filed with Hong Kong Trading and Settlement Limited on 4 January 2024 its Monthly Securities Change Report for the year ended 31 December 2023. The report showed that the company's regulated/registered share capital deposit remained at $1,000,000,000 with a face value of $0.00005 per share for a total of $50,000. In terms of issued shares, 457,813,108 shares outstanding at the end of the month, an increase of 1,996 shares compared to the previous month. The increase stems from 1,996 share purchase options under the Initial Public Offering pre-IPO incentive plan executed in December 2023. In addition, the shares repurchased by the Company between June and October 2023 have not been written off, totaling 9,058,500 shares. No information on Hong Kong pre-trust securities is mentioned in the report. Executive Director Chen Yi Yiu confirms that all securities issuance is authorized by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Novi Health filed with Hong Kong Trading and Settlement Limited on 4 January 2024 its Monthly Securities Change Report for the year ended 31 December 2023. The report showed that the company's regulated/registered share capital deposit remained at $1,000,000,000 with a face value of $0.00005 per share for a total of $50,000. In terms of issued shares, 457,813,108 shares outstanding at the end of the month, an increase of 1,996 shares compared to the previous month. The increase stems from 1,996 share purchase options under the Initial Public Offering pre-IPO incentive plan executed in December 2023. In addition, the shares repurchased by the Company between June and October 2023 have not been written off, totaling 9,058,500 shares. No information on Hong Kong pre-trust securities is mentioned in the report. Executive Director Chen Yi Yiu confirms that all securities issuance is authorized by the Board of Directors and complies with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more